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Abstract
Introduction: An "overlap syndrome" is defined as the sequential appearance over time of two
or more risk factors for glaucomatous damage. The appearance of a new risk factor can alter the
course and prognosis of previously stable disease. Exfoliation syndrome is a leading cause of
glaucoma and is associated with vascular disease. We report a case of central retinal artery
occlusion and non-arteritic anterior ischemic optic neuropathy in a patient with overlap syndrome.
Case presentation: An 87-year-old woman with longstanding stable primary open-angle
glaucoma developed bilateral exfoliation syndrome, after which her intraocular pressure became
uncontrolled and her glaucomatous damage progressed rapidly. She also developed ischemic
arterial events in both eyes.
Conclusion: The case presented here shows that overlap syndromes can lead to rapid,
irreversible vision impairment. To the best of our knowledge, this is the first reported case of
central retinal artery occlusion and non-arteritic anterior ischemic optic neuropathy in a patient
with overlap syndrome.
Introduction
The glaucomas comprise a group of diseases that result in
a common final pathway of progressive retinal ganglion
cell death, characterized by a specific pattern of optic
nerve head and visual field damage. Elevated intraocular
pressure (IOP) is the most important risk factor for glau-
comatous damage, but is not the disease itself, as was erro-
neously conceptualized in the past. In primary open-angle
glaucoma (POAG), no ocular findings beyond the optic
disc damage and (sometimes) elevated IOP are present on
examination.
Exfoliation syndrome (XFS) is an age-related disorder,
which is the most common identifiable cause of open-
angle glaucoma worldwide, accounting for the majority of
cases in some countries [1]. XFS is characterized by the
Published: 17 December 2008
Journal of Medical Case Reports 2008, 2:389 doi:10.1186/1752-1947-2-389
Received: 31 July 2008
Accepted: 17 December 2008
This article is available from: http://www.jmedicalcasereports.com/content/2/1/389
© 2008 Lima et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 4
(page number not for citation purposes)
Journal of Medical Case Reports 2008, 2:389 http://www.jmedicalcasereports.com/content/2/1/389production and progressive accumulation of a fibrillar
material, not only in the extracellular matrix of ocular tis-
sues, but also in the skin and connective tissue portions of
various visceral organs [2,3]. It usually presents unilater-
ally and when bilateral, the eyes are often markedly asym-
metrically involved [4,5]. Elevated IOP occurs in about
25% of persons with XFS, and glaucoma is present in
about one-third of these [6,7]. XFS has a more serious
clinical course and prognosis than POAG [2]. It is more
aggressive and presents with higher IOP values than
POAG [5]. Its association with cardiovascular events, such
as ischemic heart disease, is being increasingly described
[8].
The term "overlap syndrome" has been used to describe
the sequential appearance over time of two or more risk
factors for glaucomatous damage and it can alter the
course and prognosis of the disease [9]. Because both
POAG and XFS are common, one would expect some indi-
viduals with POAG to develop XFS as an additional risk
factor in older age. Nevertheless, this phenomenon has
not been widely recognized or reported in the literature.
We describe such a patient who developed rapid progres-
sion of glaucomatous damage and severe ocular ischemic
events.
Case presentation
An 87-year-old woman with type-2 diabetes and systemic
hypertension presented with a history of POAG in both
eyes (OU) for nearly 10 years. The damage was moderate
and the progression rate had been relatively slow. On her
initial examination, best corrected visual acuity (BCVA)
was 20/30 in the right eye (OD) and 20/40 in the left eye
(OS). Biomicroscopy was normal and IOP was 21 mmHg
OU on antiglaucoma medications.
One year later, she had developed exfoliation material
(XFM) on the anterior lens capsule and pupillary margin
OS (Figure 1). Her IOP was 24 mmHg OD and 34 mmHg
OS. Gonioscopy showed open-angles OU with visualiza-
tion of XFM on the trabecular meshwork OS. Fundoscopy
showed a cup-to-disc ratio of 0.5 and 0.7, respectively.
This asymmetry of structural damage was attributed to the
XFS onset and additional antiglaucoma topical treatment
was initiated OS. Six months later, the patient complained
of a marked decrease of vision OS, and a central retinal
artery occlusion (CRAO) was confirmed by clinical and
fluorescein angiographic examinations. Over the follow-
ing 3 years, the glaucoma damage advanced OS due to
uncontrolled IOP, despite treatment (Figure 2). At this
time, she refused surgical or laser intervention. The OS
presented an enlarged cup-to-disc ratio (0.9–1.0) and her
visual acuity dropped to counting fingers at two inches
(Figure 3). Several months later, XFM was noted on OD
and the IOP had increased to 30 mmHg, followed by
rapid glaucoma damage progression. After 2 years, cup-to-
disc ratio was of 0.8 OD and 1.0 OS.
During the last year of follow-up, the patient developed
further bilateral visual impairment. BCVA was 20/70 OD
and light perception OS, and IOP was 30 mmHg OD and
62 mmHg OS. Fundus examination OD revealed a pale
optic nerve head, despite no visible glaucoma structural
progression, which was diagnosed as a non-arteritic ante-
rior ischemic optic neuropathy (NAION) after clinical and
visual field examinations (Figure 4).
Discussion
Our patient had POAG in both eyes for almost 10 years.
Her disease course was stable until she developed XFS, fol-
Biomicroscopy of the left eye showing exfoliation material on the anterior lens capsule and pupillary margin (white a rows)F gure 1
Biomicroscopy of the left eye showing exfoliation 
material on the anterior lens capsule and pupillary 
margin (white arrows).
Intraocular pressure readings for both eyes along 6 years of follow- pFigure 2
Intraocular pressure readings for both eyes along 6 
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vascular events OU non-simultaneously. The progression
of her glaucoma followed the development of XFS in each
eye, associated with markedly increased IOP.
We believe that this patient can be considered as having
an overlap syndrome [9]. The appearance of a new risk
factor in a patient whose condition has been stable is sug-
gested by loss of control of the IOP or acceleration of disc
and visual field damage after a long period of stability.
The appearance of a new disease, XFS in this case, which
also leads to glaucomatous damage, altered the course
and prognosis of the POAG which had been stable for
almost 10 years.
The underlying risk factors beyond elevated IOP for
POAG remain largely unknown. Elevated IOP is a sign of
trabecular dysfunction and increased aqueous outflow
resistance, but events at the genetic and molecular levels
predisposing the trabecular meshwork to developing ele-
vated IOP are only just beginning to be elaborated. Muta-
tions in the gene coding for myocilin have been best
described. The gene coding for optineurin has been
sequenced and associated with a minority of patients with
normal-tension glaucoma. Other loci have been identi-
fied, but the associated genes have not yet been identified.
Presumably, many different genes will eventually be dis-
covered to be causative. Nonetheless, these abnormalities
constitute risk factors for the development of POAG. In
the same way, recent advances in the understanding of the
pathogenesis of XFS have lead to the discovery of a dis-
ease-related genotype that could help explain the systemic
and ocular findings in these patients. Briefly, the lysyl oxi-
dase-like 1 (LOXL-1) gene snip-out could be responsible
along with other genes for the aging process of different
A) Fundus picture showing an advanced glaucomatous damage with complete loss of neuroretinal rim in the left eyeFigure 3
A) Fundus picture showing an advanced glaucomatous damage with complete loss of neuroretinal rim in the 
left eye. B) Central visual field test (10°) showing a complete loss of sensitivity in the same eye.
A) Fundus picture showing a pale optic nerve head and advanced glaucomatous damage in the right eyeFigure 4
A) Fundus picture showing a pale optic nerve head and advanced glaucomatous damage in the right eye. B) Vis-
ual field (24°) showing a superior arcuate scotoma and a significant loss of sensitivity inferiorly in the same eye.Page 3 of 4
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vascular endothelium.
An increasing number of reports have demonstrated an
association between XFS and systemic vascular events,
including hypertension, angina, myocardial infarction
and stroke [8,10]. Elevated plasma homocysteine levels, a
risk factor for cardiovascular disease, are more common in
XFS and XFG patients than in healthy controls [11]. XFS is
associated with branch and central retinal vein occlusion
[12,13]. Hyperhomocysteinemia is associated with central
retinal vein occlusion, NAION and CRAO [14,15]. After
developing XFS, our patient experienced two serious ocu-
lar arterial occlusive events, respecting the laterality of the
XFS onset. We understand that all of the features noted in
this case reinforce the hypothesis that the development of
an overlap syndrome was associated with the onset of the
ocular vascular events. To the best of our knowledge, this
is the first reported case of CRAO and NAION in a patient
with overlap syndrome.
It is important to stress some clinical implications of this
case report. First, since XFS is yet untreatable and seems to
be an additional risk factor for vascular complications in
older patients, it is important to have strict clinical control
of the other systemic comorbidities associated with cardi-
ovascular diseases, such as diabetes and systemic hyper-
tension. Second, if a POAG patient develops XFS, careful
follow-up is advised, since the disease progression could
be rapid. It is known that the amount of visible XFM in the
anterior chamber may vary significantly in eyes with XFS.
Therefore, it is very important to perform a careful exami-
nation of any POAG patient presenting with progressive
IOP increase despite current treatment, in order to rule
out a possible overlap syndrome. Finally, although pre-
senting with an initial asymmetric onset, XFS can severely
affect both eyes. Thus, close monitoring of the fellow-eye
is important in clinical unilateral cases.
Conclusion
Overlap syndrome (described here as a combination of
POAG and XFS) might lead to a rapidly and irreversible
vision impairment due to glaucoma damage progression.
Moreover, it can be accompanied by other ocular comor-
bidities, such as vascular occlusive events, which can also
threaten vision function.
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